ArticleJournal of Cancer2019

Immunopotentiator Aikejia improves the therapeutic efficacy of PD-1/PD-L1 immunosuppressive pathway in CT26.WT cancer cell.

Chaoqun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.